← FDA DRUG APPROVALS

FDA ANDA · ANDA073617

PENTAMIDINE ISETHIONATE

Sponsor: BAXTER HLTHCARE

APPLICATION
ANDA073617
TYPE
ANDA
ORIGINAL APPROVAL
1995-12-18
LATEST ACTION
1997-07-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PENTAMIDINE ISETHIONATEDiscontinued
PENTAMIDINE ISETHIONATE 300MG/VIAL · INJECTABLE · INJECTION

Approval history

1997-07-11Labeling · Supplement 2AP
1996-09-18Labeling · Supplement 1AP
1995-12-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →